Our mission
Improve the clinical outcome for Quebec cancer patients
by developing and offering novel therapeutic options.
Last news
FRQS Cancer Research Network, TFRI and QCC joint symposium
On September 23, 2022, the RR Cancer, the QCC and the TFRI-Québec Node jointly hosted a biennial symposium at ... Read more
A new direction at Réseau Recherche Cancer
After completing the change of management process according to the rules of the Fonds de recherche du Québec – ... Read more
Matériel éducatif pour les patients @QConsortium Voici le récit d’une étude clinique à laquelle ont participé une patiente, atteinte d’un cancer du pancréas métastatique, et son médecin traitant, le Dr Gerald Batist. Vidéo ➡️https://youtu.be/BchIB1ousNs
Discover the Educational Material for patients @QConsortium The story of a patient undergoing clinical trials for her metastatic pancreatic cancer. We meet Dr. Gerald Batist director of the MCTRC & of the Segal cancer center at the Jewish General Hospital https://youtu.be/BchIB1ousNs
Félicitations @BertrandRouty!
The recipients are:
1⃣. Dr. Bertrand Routy, @CRCHUM (Montreal) for: How microbiomes influence intratumour immune contexture and response to immune-checkpoint inhibitors in patients with non-small cell lung cancer #LungCancer
More ▶️ https://bit.ly/3USWJCN @BertrandRouty
Félicitations @DrLefrancoisLDI!
🍁 Introducing our Clinician-Scientist Award Recipients 🍁
Dr. Philippe Lefrançois is a dermatologist and researcher @LDI_ILD & @McGill_DOM.
His project will focus on understanding why a small fraction of basal cell carcinomas become extremely aggressive. @DrLefrancoisLDI
